CLINICAL_TRIALS
trial_result
· 2017-06-07
Clinical Trial Update: Effect of Dalfampridine (4-AP) on Genioglossus Muscle Activity in Healthy Adults [Phase 2]
Summary
Phase 2 trial assessing dalfampridine's effect on genioglossus muscle activity related to obstructive sleep apnea; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Brigham and Women's Hospital | Conditions: Sleep Apnea, Obstructive | Phase 2 | Status: COMPLETED | Results posted: 2017-06-07